Plus ça change ... antiretroviral therapy, HIV prevention, and the HIV treatment cascade.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

1. Understanding the Time Needed to Link to Care and Start ART in Seven HPTN 071 (PopART) Study Communities in Zambia and South Africa.AIDS and behavior · 2019
   Trial
2. Sociodemographic determinants of attrition in the HIV continuum of care in Brazil, in 2016.Medicine · 2018
   Article
3. 'Test and Treat' Among Women at High Risk for HIV-infection in Kampala, Uganda: Antiretroviral Therapy Initiation and Associated Factors.AIDS and behavior · 2018
   Article
4. An Adaptive Approach to Locating Mobile HIV Testing Services.Medical decision making : an international journal of the Society for Medical Decision Making · 2018
   Article
5. Measures of human immunodeficiency virus (HIV) community viral load and HIV incidence among people who inject drugs.Annals of epidemiology · 2018
   Article
6. The impact of routine data quality assessments on electronic medical record data quality in Kenya.PloS one · 2018
   Article
7. Considerations for the Development of a Substance-Related Care and Prevention Continuum Model.Frontiers in public health · 2017
   Article
8. Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment.AIDS (London, England) · 2016
   Article
9. Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey.PloS one · 2016
   Article
10. Conceptualizing Care Continua: Lessons from HIV, Hepatitis C Virus, Tuberculosis and Implications for the Development of Improved Care and Prevention Continua.Frontiers in public health · 2016
    Review
11. Progress in Reversing the HIV Epidemic through Intensified Access to Antiretroviral Therapy: Results from a Nationally Representative Population-Based Survey in Kenya, 2012.PloS one · 2016
    Article
12. HIV serostatus disclosure in the treatment cascade: evidence from Northern Tanzania.AIDS care · 2015
    Article
13. Linkage to and engagement in HIV care in western Kenya: an observational study using population-based estimates from home-based counselling and testing.The lancet. HIV · 2015
    Observational

Corrections and comments

• Comment on
  Antiretroviral therapy for the prevention of HIV transmission: what will it take?2014

Authors and funding

1 author at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as